Current approach in the treatment of hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Current approach in the treatment of hepatocellular carcinoma.

Current approach in the treatment of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q41133765

about

Modulation of Autophagy by Sorafenib: Effects on Treatment Response Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials.Diagnostic challenges in primary hepatocellular carcinoma: case reports and review of the literature Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation Prevalence of K-Ras mutations in hepatocellular carcinoma: A Turkish Oncology Group pilot study.Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease.The VEGF pathway in cancer and disease: responses, resistance, and the path forward.Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy.Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.Hepatoid Adenocarcinoma of the Gallbladder : Case Report and Literature Review.Targeting the vasculature of visceral tumors: novel insights and treatment perspectives.Long non-coding RNA XIST promotes cell growth by regulating miR-139-5p/PDK1/AKT axis in hepatocellular carcinoma.Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration.Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence.A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.Suppression of the Wnt signaling pathway may contribute to the inhibition of proliferation of human hepatocellular carcinoma SMMC-7721 cells by esculetin.Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma.Radiofrequency ablation versus reresection in treating recurrent hepatocellular carcinoma: a meta-analysis.5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction.Liver resection for hepatocellular carcinoma in patients without cirrhosis.Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory response.Adjuvant interferon therapy after surgical treatment for hepatitis B/C virus-related hepatocellular carcinoma: A meta-analysis.Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition.LncRNA-NEF antagonized epithelial to mesenchymal transition and cancer metastasis via cis-regulating FOXA2 and inactivating Wnt/β-catenin signaling.Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria.[Selective internal radioembolization in nonresectable hepatocellular carcinoma].A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma Interventionelle Therapie von Lungen- und Lebermetastasen Interventionelle Therapie primärer Lebertumoren

P2860

Q26745320-10B51191-FF17-4C59-A03D-BA049CD12628 Q28547457-28D04157-80C1-46B9-99AB-11BD8380E070 Q33913779-94DA8FCB-7C68-4C07-875F-E6A1FBC767A2 Q34531474-8BD895B5-D08E-4A76-92DB-C38D62DB2B7E Q35421349-F046F84D-F115-4821-A2BB-F8BCB93ADE94 Q35865503-F8BF69D1-68F5-4D13-955B-814EF615C7A5 Q36335286-73258288-55A2-4A8E-B9D8-ED8520BBADCB Q36357360-2D659A32-C0F9-4347-BF61-BB81E688B6E5 Q36526512-417D766C-2856-4290-A314-129408FDF5D5 Q37031758-C7B09708-64BE-42B4-870B-18365C58710D Q37153412-377B5D07-8DBC-47F4-BDE5-6EBE24974A22 Q37606028-5586D5D0-5660-4C26-805B-611AB5FDB6A5 Q37680236-EAFC749D-609D-4628-A387-52155FB420F9 Q37709160-EFF18D1C-9A89-4F9A-AFDA-E7A0FB5D9E1D Q37936344-95E8E90A-4E71-45CD-8D3D-FF7933004E0D Q37993393-3E2ED3BE-45FC-4D37-B0C2-FFC556587E53 Q38715197-65C2EE64-B3CF-404F-8CA1-EA5514E971FE Q38769255-88A66820-AECD-4974-9042-0DCF4637C16D Q38933888-9152C010-4A14-4259-B88E-4836254BC85E Q38975201-5BE0BF2B-7E7D-42FA-8E81-D220A5C24AFE Q39414132-5F0B3224-7CAF-45E6-84FC-3526C74F1EAB Q39515321-141F9B07-BEBA-4E7F-808C-D5B878E1DB2E Q41143523-4CFA827C-889E-4DC6-AAC2-29E942AABB71 Q41621726-AF5AD855-1BB5-4E99-82F0-ECD74F70CBFE Q41790928-D9B44AAC-49EC-43A0-B090-F8467B572FA9 Q42673174-2BD1D42E-2B04-4565-A12D-5F66612E134D Q44615087-1B86CC4C-56C8-4A07-B706-163E3A0A4302 Q45227714-47D8483F-866D-4D0E-B21B-E455592E1006 Q45351713-E19F4622-D429-41CA-A2F2-877EB63AC0EB Q48097703-74209F13-CF83-4128-8C79-F39F46F97CFF Q48593330-79B258B4-B96F-4061-AE93-C7D4E370B707 Q50132449-4B8A05DD-0EA1-4E43-8157-BCCF5A0D3D4A Q50244060-9D2E67F4-4590-496C-AF40-CDD4D7FB201C Q53061048-0861CE52-1E0C-4582-B792-FB23DDCFD27C Q58793424-7AFDE5D3-6A44-46D8-AA9D-376C7F0FAFB4 Q58904316-7CF93B7D-5BB4-447C-BF3E-6D531B6C3E24 Q58904357-0AD57C3C-DBC9-4AA6-8E79-7ECCA970A3D2

P2860

Current approach in the treatment of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q41133765

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Current approach in the treatment of hepatocellular carcinoma.

@en

type

label

Current approach in the treatment of hepatocellular carcinoma.

@en

prefLabel

Current approach in the treatment of hepatocellular carcinoma.

@en

P1433

Q41133765-C2330DDB-0635-4A5D-91DA-59DDE9FB809C

P1476

Q41133765-ADD59FBC-378C-4849-944C-09C4BF9AFA69

P2093

Q41133765-0FF70A19-94C7-4721-8776-36AAC7E6F7EE

Q41133765-1E3FFC6F-5932-4B62-803D-88138D3A1363

Q41133765-262B97DC-9DE7-4AA8-B426-5B4EA63F6647

Q41133765-2E8FAEBA-7510-47C7-A31E-A11201043147

Q41133765-9112A9B1-DC4C-4F3B-ABDB-480134A77561

Q41133765-EFB30B0F-7AF6-4C8E-A711-92186F268495

Q41133765-F7B21B92-D662-4703-8D21-AEC989D909D8

P2860

Q41133765-001651AE-1B99-4227-84B3-81BB72A9742C

Q41133765-069AE803-0D20-413C-9D41-554A63518E98

Q41133765-0B441297-11E8-4A71-AAB2-D7600FE90FD6

Q41133765-11934BFB-9E25-4FF1-8796-3C82DD85DC1C

Q41133765-1278A2C7-928A-4523-9C70-E66FBFD5A6B8

Q41133765-13B728C5-8EC5-46FC-B7A9-3819A701EBF2

Q41133765-13E9F237-2572-4CCE-AA84-7B501DB23E3E

Q41133765-18A72DBA-3B36-44FE-8D68-1358D46709B8

Q41133765-1C245D00-1A17-41FA-994D-8D4D0A67BF86

Q41133765-248FE87C-6E9A-42EE-8245-2E11412B0234

P304

Q41133765-7B5D42B4-9825-4BBD-87C5-1ACD02D16E2E

P31

Q41133765-70637663-5898-45d0-bf4f-23b0796c1226

Q41133765-B6BDC7E8-A342-4C08-BFDA-8430B325B7EA

P356

Q41133765-051F64B3-15BD-4E8B-AA45-BF82FA1A76D5

P433

Q41133765-708D1FD9-14EC-461A-BEA6-2181E0DF55DF

P478

Q41133765-C6EDA654-38BA-4D67-9A6A-B0F72BD10765

P577

Q41133765-536D4FBE-5250-4080-9627-A46B152527C8

P5875

Q41133765-8E96359C-A610-440A-9ACD-83C9E617E907

P698

Q41133765-D82F7359-A247-4DA4-B672-33313AFB8A50

P932

Q41133765-9B0862D4-5D7B-4A65-8DA9-9A5F39562446

P356

P1433

World journal of gastrointestinal oncology

P1476

Current approach in the treatment of hepatocellular carcinoma.

@en

P2093

Anselmo Papa

http://www.w3.org/2001/XMLSchema#string

Federica Zoratto

http://www.w3.org/2001/XMLSchema#string

Francesca Iodice

http://www.w3.org/2001/XMLSchema#string

Luigi Frati

http://www.w3.org/2001/XMLSchema#string

Luigi Rossi

http://www.w3.org/2001/XMLSchema#string

Marina Minozzi

http://www.w3.org/2001/XMLSchema#string

Silverio Tomao

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Cetuximab for the treatment of colorectal cancer.

Global cancer statistics, 2002

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Sorafenib in advanced hepatocellular carcinoma

The protein tyrosine kinase family of the human genome

Yttrium-90 microspheres: radiation therapy for unresectable liver cancer

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

P304

348-359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4251/WJGO.V2.I9.348

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49685839

http://www.w3.org/2001/XMLSchema#string

P698

21160806

http://www.w3.org/2001/XMLSchema#string

P932

2999141

http://www.w3.org/2001/XMLSchema#string